| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 1595.3 | 1486.1 | 1462.5 |
| Other income | 16.9 | 39.3 | 19.1 |
| Total income | 1612.2 | 1525.4 | 1481.6 |
| Profit before exceptional items & tax | 490.6 | 444.1 | 477.6 |
| Exceptional items | -16.6 | -8.4 | 0.0 |
| Profit before tax | 474.0 | 435.7 | 477.6 |
| Net profit | 353.3 | 323.9 | 355.0 |
| Operating margin | 29.4% | 28.6% | 32.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -0.50% |
|---|---|
| Net profit, quarter on quarter | +9.10% |
| Revenue, year on year | +9.10% |
BSE results filing, NSE: COLPAL. Figures extracted from the filing.
Colgate-Palmolive (India) Ltd: key numbers
- Share price
- ₹1,809.40
- Market cap
- ₹49,213 Cr
- Revenue (annual)
- ₹6,035 Cr
- Net profit (annual)
- ₹1,325 Cr
- P/E (TTM)
- 36.5×Sector 42.5×
- Promoter holding
- 51.00%+0.00% QoQ
- FII holding
- 13.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Colgate-Palmolive (India) Ltd
All →Colgate-Palmolive (India) Business Update
Colgate-Palmolive (India) has partnered with Kaun Banega Crorepati Season 18 to integrate oral health awareness messages into the show's daily narrative through unique celebrity sign-offs.
Colgate-Palmolive (India) Management Change
Colgate-Palmolive (India) Limited announced the resignation of Mr. G. Ramprasad as its Internal Auditor, effective August 31, 2026, to explore other opportunities.
Colgate-Palmolive (India) Earnings Call Transcript: Key Takeaways
Colgate-Palmolive (India) reported Q1 sales of Rs. 1591 crores, a 12% increase. Strategy focuses on driving oral care consumption and premiumisation, with premium segments growing 5X faster than competitors.
Colgate-Palmolive (India) Management Change
Colgate-Palmolive (India) announced the resignation of MD & CEO Prabha Narasimhan, effective September 27, 2026. Manish Anandani succeeds her as MD & CEO effective September 28, 2026.
Colgate-Palmolive (India) Business Update
Colgate-Palmolive's PerioGard portfolio became India's first gum care regimen to earn the Indian Society of Periodontology's (ISP) Seal of Acceptance for its clinical standards.
Colgate-Palmolive (India) Investor Presentation: Key Takeaways
Colgate India reported robust Q1 FY27 net sales growth of 12% YoY, accelerating from 9% in the previous quarter. The company is focused on category growth through premiumization and expanding rural toothbrush penetration.